Ервой Ипилимумаб fifty one Bottle BRISTOL MYERS Indications for Use \r\n Yervoy is used to treat melanoma, small cell and non-small cell lung cancer, and metastatic prostate cancer. \r\n Directions for Use \r\n Yervoy is administered intravenously every four days per week for a three-week course of treatment. Yervoy shows the best results when administered as a primary treatment. Clinical trials have shown that Yervoy significantly prolongs the survival of patients with late-stage melanoma.
Yervoy (ipilimumab) 50 mg/10 mL, 1 vial, Bristol Myers
Article:
In Stock
Indications for Use
Yervoy is used to treat melanoma, small cell and non-small cell lung cancer, and metastatic prostate cancer.
Directions for Use
Yervoy is administered intravenously every four days per week for a three-week course of treatment. Yervoy shows the best results when administered as a primary treatment. Clinical trials have shown that Yervoy significantly prolongs the survival of patients with late-stage melanoma.
- Commercial name:Ервой
- Сhemical name:Ипилимумаб
- Dosage:fifty
- Quantity:one
- Release form:Bottle
- Производитель:BRISTOL MYERS
No reviews yet